BioCentury
ARTICLE | Clinical News

CytRx preclinical data

March 23, 2009 7:00 AM UTC

In a rat model of diabetes, iroxanadine improved diabetic peripheral neuropathy as measured by sensory nerve conduction velocity (SCNV) and compound muscle action potential (CMAP) latency. The small m...